Chinese Vaccine Coronavac
- All
- News
-
Chinese Covid Vaccine Safe, Effective In Children, Adolescents: Lancet Study
Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
-
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To "Adverse Incident"
Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
-
Chinese Covid Vaccine Safe, Effective In Children, Adolescents: Lancet Study
Two doses of the China-made COVID-19 vaccine, CoronaVac, are safe and produce a strong antibody response among children and adolescents aged 3-17 years, according to a study published in The Lancet Infectious Diseases journal.
-
China Authorises CoronaVac COVID-19 Vaccine For Children Above 3 Years
China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said.
-
Chinese Covid Vaccine "Reached Efficacy Threshold": Brazil Institute
Clinical trials of the CoronaVac coronavirus vaccine developed by Chinese laboratory Sinovac have "reached the efficacy threshold" demanded by the World Health Organization, the Brazilian institute charged with its production and distribution said on Wednesday.
-
Brazil Suspends Trials Of Chinese Covid-19 Vaccine Due To "Adverse Incident"
Brazil's health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an "adverse incident" involving a volunteer recipient, a blow for one of the most advanced vaccine candidates.
